
Kalytera Therapeutics Appoints Dr. Andrew Salzman as Chief Medical Officer
MANHATTAN BEACH, CA -- (Marketwired) -- 08/23/16 -- Kalytera Therapeutics, Inc., a pharmaceutical company developing a portfolio of proprietary cannabinoid and endocannabinoid-like medicines, today announced the appointment of Andrew L. Salzman, M.D. as …